ATH434 Eases Constipation, Other GI Symptoms in Mouse Model

ATH434 Eases Constipation, Other GI Symptoms in Mouse Model

311450

ATH434 Eases Constipation, Other GI Symptoms in Mouse Model

An investigational therapy, ATH434 was able to reverse some gastrointestinal problems in a mouse model of Parkinson’s disease, according to its developer Alterity Therapeutics. “Practicing clinicians are well aware of the substantial impact that these symptoms have on the quality of life of individuals with Parkinson’s disease,” David Stamler, MD, CEO of Alterity, said in a press release. “We are currently conducting additional preclinical studies to evaluate the potential of ATH434 for the treatment of PD [Parkinson’s…

You must be logged in to read/download the full post.